# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-26-058234
Filing Date
2026-05-11
Accepted
2026-05-11 06:45:35
Documents
23
Period of Report
2026-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2614109d1_8k.htm iXBRL | 8-K | 26415
2 | EXHIBIT 99.1 | tm2614109d1_ex99-1.htm | EX-99.1 | 72413
3 | EXHIBIT 99.2 | tm2614109d1_ex99-2.htm | EX-99.2 | 16249
7 | GRAPHIC | tm2614109d1_ex99-2img001.jpg | GRAPHIC | 94843
8 | GRAPHIC | tm2614109d1_ex99-2img002.jpg | GRAPHIC | 336643
9 | GRAPHIC | tm2614109d1_ex99-2img003.jpg | GRAPHIC | 171614
10 | GRAPHIC | tm2614109d1_ex99-2img004.jpg | GRAPHIC | 170784
11 | GRAPHIC | tm2614109d1_ex99-2img005.jpg | GRAPHIC | 147596
12 | GRAPHIC | tm2614109d1_ex99-2img006.jpg | GRAPHIC | 177479
13 | GRAPHIC | tm2614109d1_ex99-2img007.jpg | GRAPHIC | 134760
14 | GRAPHIC | tm2614109d1_ex99-2img008.jpg | GRAPHIC | 136607
15 | GRAPHIC | tm2614109d1_ex99-2img009.jpg | GRAPHIC | 110482
16 | GRAPHIC | tm2614109d1_ex99-2img010.jpg | GRAPHIC | 141168
| Complete submission text file | 0001104659-26-058234.txt |  | 2534939

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | lqda-20260511.xsd | EX-101.SCH | 3014
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lqda-20260511_lab.xml | EX-101.LAB | 34239
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lqda-20260511_pre.xml | EX-101.PRE | 22358
26 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2614109d1_8k_htm.xml | XML | 3180

Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 26960775
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)